These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18213618)

  • 1. Comprehensive analysis of LRRK2 in publicly available Parkinson's disease cases and neurologically normal controls.
    Paisán-Ruíz C; Nath P; Washecka N; Gibbs JR; Singleton AB
    Hum Mutat; 2008 Apr; 29(4):485-90. PubMed ID: 18213618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive screening of a North American Parkinson's disease cohort for LRRK2 mutation.
    Johnson J; Paisán-Ruíz C; Lopez G; Crews C; Britton A; Malkani R; Evans EW; McInerney-Leo A; Jain S; Nussbaum RL; Foote KD; Mandel RJ; Crawley A; Reimsnider S; Fernandez HH; Okun MS; Gwinn-Hardy K; Singleton AB
    Neurodegener Dis; 2007; 4(5):386-91. PubMed ID: 17622782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRRK2 gene in Parkinson disease: mutation analysis and case control association study.
    Paisán-Ruíz C; Lang AE; Kawarai T; Sato C; Salehi-Rad S; Fisman GK; Al-Khairallah T; St George-Hyslop P; Singleton A; Rogaeva E
    Neurology; 2005 Sep; 65(5):696-700. PubMed ID: 16157901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LRRK2 gene variation and its contribution to Parkinson disease.
    Paisán-Ruiz C
    Hum Mutat; 2009 Aug; 30(8):1153-60. PubMed ID: 19472409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel LRRK2 mutation in an Austrian cohort of patients with Parkinson's disease.
    Haubenberger D; Bonelli S; Hotzy C; Leitner P; Lichtner P; Samal D; Katzenschlager R; Djamshidian A; Brücke T; Steffelbauer M; Bancher C; Grossmann J; Ransmayr G; Strom TM; Meitinger T; Gasser T; Auff E; Zimprich A
    Mov Disord; 2007 Aug; 22(11):1640-3. PubMed ID: 17523199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for SNCA and LRRK2 mutations in Greek sporadic and autosomal dominant Parkinson's disease: identification of two novel LRRK2 variants.
    Xiromerisiou G; Hadjigeorgiou GM; Gourbali V; Johnson J; Papakonstantinou I; Papadimitriou A; Singleton AB
    Eur J Neurol; 2007 Jan; 14(1):7-11. PubMed ID: 17222106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late-onset Parkinson's disease.
    Tan EK; Skipper L; Chua E; Wong MC; Pavanni R; Bonnard C; Kolatkar P; Liu JJ
    Mov Disord; 2006 Jul; 21(7):997-1001. PubMed ID: 16602113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8.
    Nichols WC; Elsaesser VE; Pankratz N; Pauciulo MW; Marek DK; Halter CA; Rudolph A; Shults CW; Foroud T;
    Neurology; 2007 Oct; 69(18):1737-44. PubMed ID: 17804834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries.
    Tomiyama H; Li Y; Funayama M; Hasegawa K; Yoshino H; Kubo S; Sato K; Hattori T; Lu CS; Inzelberg R; Djaldetti R; Melamed E; Amouri R; Gouider-Khouja N; Hentati F; Hatano Y; Wang M; Imamichi Y; Mizoguchi K; Miyajima H; Obata F; Toda T; Farrer MJ; Mizuno Y; Hattori N
    Mov Disord; 2006 Aug; 21(8):1102-8. PubMed ID: 16622854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRRK2 exon 41 mutations in sporadic Parkinson disease in Europeans.
    Lesage S; Janin S; Lohmann E; Leutenegger AL; Leclere L; Viallet F; Pollak P; Durif F; Thobois S; Layet V; Vidailhet M; Agid Y; Dürr A; Brice A; ; Bonnet AM; Borg M; Broussolle E; Damier P; Destée A; Martinez M; Penet C; Rasco O; Tison F; Tranchan C; Vérin M
    Arch Neurol; 2007 Mar; 64(3):425-30. PubMed ID: 17353388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.
    Clark LN; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Neurology; 2006 Nov; 67(10):1786-91. PubMed ID: 17050822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lrrk2 pathogenic substitutions in Parkinson's disease.
    Mata IF; Kachergus JM; Taylor JP; Lincoln S; Aasly J; Lynch T; Hulihan MM; Cobb SA; Wu RM; Lu CS; Lahoz C; Wszolek ZK; Farrer MJ
    Neurogenetics; 2005 Dec; 6(4):171-7. PubMed ID: 16172858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing association between LRRK2 and Parkinson's disease and investigating linkage disequilibrium.
    Paisán-Ruíz C; Evans EW; Jain S; Xiromerisiou G; Gibbs JR; Eerola J; Gourbali V; Hellström O; Duckworth J; Papadimitriou A; Tienari PJ; Hadjigeorgiou GM; Singleton AB
    J Med Genet; 2006 Feb; 43(2):e9. PubMed ID: 16467219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LRRK2 mutations in a clinic-based cohort of Parkinson's disease.
    Scholz S; Mandel RJ; Fernandez HH; Foote KD; Rodriguez RL; Barton E; Munson S; Singleton A; Okun MS
    Eur J Neurol; 2006 Dec; 13(12):1298-301. PubMed ID: 17116211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in LRRK2 as a cause of Parkinson's disease.
    Giasson BI; Van Deerlin VM
    Neurosignals; 2008; 16(1):99-105. PubMed ID: 18097165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive sequencing of the LRRK2 gene in patients with familial Parkinson's disease from North Africa.
    Jasinska-Myga B; Kachergus J; Vilariño-Güell C; Wider C; Soto-Ortolaza AI; Kefi M; Middleton LT; Ishihara-Paul L; Gibson RA; Amouri R; Yahmed SB; Sassi SB; Zouari M; El Euch G; Ross OA; Hentati F; Farrer MJ
    Mov Disord; 2010 Oct; 25(13):2052-8. PubMed ID: 20721913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of the effect of LRRK2 exonic variants on the risk of Parkinson's disease: a meta-analysis.
    Wu X; Tang KF; Li Y; Xiong YY; Shen L; Wei ZY; Zhou KJ; Niu JM; Han X; Yang L; Feng GY; He L; Qin SY
    Parkinsonism Relat Disord; 2012 Jul; 18(6):722-30. PubMed ID: 22575234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common variants of LRRK2 are not associated with sporadic Parkinson's disease.
    Biskup S; Mueller JC; Sharma M; Lichtner P; Zimprich A; Berg D; Wüllner U; Illig T; Meitinger T; Gasser T
    Ann Neurol; 2005 Dec; 58(6):905-8. PubMed ID: 16254973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence/rarity of commonly reported LRRK2 mutations in Indian Parkinson's disease patients.
    Punia S; Behari M; Govindappa ST; Swaminath PV; Jayaram S; Goyal V; Muthane UB; Juyal RC; Thelma BK
    Neurosci Lett; 2006 Dec; 409(2):83-8. PubMed ID: 17052850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
    Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA
    Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.